ACUITY HORIZONS bleeding criteria: Difference between revisions
Jump to navigation
Jump to search
| Line 14: | Line 14: | ||
* Reduction in hemoglobin concentration of ≥3 g/dL with an overt source of bleeding | * Reduction in hemoglobin concentration of ≥3 g/dL with an overt source of bleeding | ||
* Reoperation for [[bleeding]] | * Reoperation for [[bleeding]] | ||
* Use of any blood product transfusion}}<ref name="pmid20213257">{{cite journal| author=Amlani S, Nadarajah T, Afzal R, Pal-Sayal R, Eikelboom JW, Natarajan MK| title=Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction. | journal=J Thromb Thrombolysis | year= 2010 | volume= 30 | issue= 4 | pages= 434-40 | pmid=20213257 | doi=10.1007/s11239-010-0462-8 | pmc= | url= }} </ref> | * Use of any blood product transfusion}}<ref name="pmid20213257">{{cite journal| author=Amlani S, Nadarajah T, Afzal R, Pal-Sayal R, Eikelboom JW, Natarajan MK| title=Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction. | journal=J Thromb Thrombolysis | year= 2010 | volume= 30 | issue= 4 | pages= 434-40 | pmid=20213257 | doi=10.1007/s11239-010-0462-8 | pmc= | url= }}</ref> | ||
== References == | == References == | ||
Revision as of 17:22, 27 March 2013
|
Bleeding Microchapters |
|
Treatment |
|---|
|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
|
Perioperative Bleeding |
|
ACUITY HORIZONS bleeding criteria On the Web |
|
American Roentgen Ray Society Images of ACUITY HORIZONS bleeding criteria |
|
Risk calculators and risk factors for ACUITY HORIZONS bleeding criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Acuity Horizons Bleeding Criteria
ACUITY, HORIZONS
| “ |
Major
|
” |
References
- ↑ Amlani S, Nadarajah T, Afzal R, Pal-Sayal R, Eikelboom JW, Natarajan MK (2010). "Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction". J Thromb Thrombolysis. 30 (4): 434–40. doi:10.1007/s11239-010-0462-8. PMID 20213257.